Winstrol (Stanozolol) 25 mg – 100 Tablets
Description
Biochem Winstrol (Stanozolol) 25 mg – Oral Anabolic-Androgenic Steroid Tablets
Biochem Winstrol (Stanozolol) 25 mg – 100 Tablets is a product containing stanozolol, a synthetic anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). Stanozolol belongs to the class of androgen receptor agonists and has historically been used in selected medical settings, including the prevention of attacks associated with hereditary angioedema.
Stanozolol became commercially associated with the pharmaceutical brand name Winstrol. Historically, it has been manufactured in both oral tablet and injectable suspension formulations, although these preparations differ in pharmaceutical composition and administration characteristics.
Stanozolol possesses a distinctive molecular structure incorporating a pyrazole ring fused to the steroid nucleus. This structural feature differentiates it from testosterone, methandrostenolone, oxandrolone, and other synthetic anabolic-androgenic steroids.
The compound contains a 17-alpha-methyl group, which contributes to oral activity by increasing resistance to first-pass hepatic metabolism. This structural modification is also associated with clinically important liver toxicity.
Stanozolol is a DHT-derived anabolic-androgenic steroid and does not undergo aromatization into estrogen through the aromatase enzyme. Its nonaromatizing structure distinguishes it from testosterone and methandrostenolone.
The absence of aromatization does not eliminate the possibility of endocrine suppression, cardiovascular complications, adverse lipid changes, or other serious health effects.
Stanozolol acts primarily through intracellular androgen receptors, influencing gene transcription and physiological processes associated with protein metabolism, nitrogen balance, and androgen-dependent tissue regulation.
Historically, pharmaceutical stanozolol was prescribed in certain jurisdictions for selected conditions, including hereditary angioedema. Historical medical use does not establish current approval or availability in every country.
Stanozolol has also been associated with nonmedical bodybuilding and athletic performance enhancement. Such use carries substantial risks, and stanozolol is prohibited in competitive sport under World Anti-Doping Agency rules.
Winstrol is a pharmaceutical brand name associated with stanozolol. Use of this name in a Biochem product description does not establish that the product is authentic branded Winstrol or therapeutically equivalent to an authorized pharmaceutical preparation.
The Biochem Stanozolol product is described as containing 25 mg per tablet, with 100 tablets per package. This represents a total labeled active ingredient content of 2,500 mg (2.5 grams) per package.
The stated tablet strength is not an individual dosage recommendation. Product identity, purity, excipients, and manufacturing specifications have not been independently verified.
| Specification | Details |
|---|---|
| Product Name | Biochem Winstrol |
| Alternative Names | Winstrol / Stanozolol |
| Active Ingredient | Stanozolol |
| Associated Brand Name | Winstrol |
| Labeled Strength | 25 mg per tablet |
| Package Quantity | 100 Tablets |
| Total Labeled Active Ingredient | 2,500 mg |
| Dosage Form | Oral Tablets |
| Drug Classification | Anabolic-Androgenic Steroid |
| Molecular Classification | Synthetic Dihydrotestosterone Derivative |
| Chemical Name | 17β-Hydroxy-17α-methyl-5α-androstano[3,2-c]pyrazole |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | Approximately 328.50 g/mol |
| Structural Classification | Pyrazole-Containing Steroidal Androgen |
| Structural Modifications | Fused Pyrazole Ring and 17α-Methylation |
| Primary Receptor | Androgen Receptor (AR) |
| Receptor Activity | Androgen Receptor Agonist |
| Primary Signaling Pathway | Androgen Receptor-Mediated Gene Transcription |
| Aromatization | Does Not Undergo Aromatization to Estrogen |
| Oral Activity | Supported by 17α-Alkylation |
| Primary Metabolic Organ | Liver |
| Elimination Half-Life | Commonly Reported Around 9 Hours for Oral Preparations; Estimates Vary |
| Primary Biological Effects | Anabolic and Androgenic Activity |
| Historical Medical Context | Hereditary Angioedema and Selected Other Conditions |
| Administration | Oral in Established Tablet Formulations |
| Controlled Substance Classification | Jurisdiction-Dependent |
| Competitive Sports Status | Prohibited Under WADA Rules |
| Excipients | Not Confirmed for the Biochem Product |
| Manufacturing Specifications | Not Independently Verified |
1. Activates Androgen Receptors
Stanozolol interacts with intracellular androgen receptors expressed in skeletal muscle and other androgen-responsive tissues.
Following receptor activation, the androgen receptor complex influences transcriptional processes associated with protein metabolism, cellular regulation, and androgen-dependent physiological responses.
The extent of these effects depends on systemic exposure, receptor expression, tissue characteristics, and individual endocrine status.
2. Influences Protein Metabolism
Anabolic-androgenic steroids can influence protein synthesis and protein turnover through androgen receptor-mediated signaling.
Stanozolol has historically been associated with anabolic biological activity and changes in nitrogen balance.
These physiological effects do not establish that nonmedical administration is safe or that changes in body composition necessarily produce long-term health benefits.
3. Has Anabolic Biological Activity
Stanozolol is classified as an anabolic-androgenic steroid because it can influence tissue metabolism and androgen-dependent physiological functions.
Its distinctive pyrazole-containing structure contributes to a pharmacological profile that differs from testosterone and other synthetic anabolic steroids.
Descriptions of stanozolol as exclusively anabolic or free of androgenic effects are scientifically inaccurate.
4. Does Not Undergo Aromatization to Estrogen
Stanozolol is a DHT-derived steroid and is not converted into estrogen by aromatase.
This distinguishes it from aromatizable anabolic-androgenic steroids such as testosterone and methandrostenolone.
However, the absence of aromatization does not mean that stanozolol treats estrogen-related disorders or eliminates endocrine complications.
5. Retains Androgenic Biological Activity
Stanozolol retains androgen receptor activity and can produce androgenic adverse effects.
Potential effects include acne, increased skin oiliness, scalp hair loss in susceptible individuals, and virilization in women.
Some virilizing effects, including deepening of the voice, may be irreversible.
6. Can Suppress Endogenous Hormone Production
Exogenous anabolic-androgenic steroid exposure can suppress the hypothalamic-pituitary-gonadal axis.
This may reduce endogenous testosterone and gonadotropin production, potentially affecting reproductive function, fertility, and hormonal regulation.
The degree of suppression depends on exposure and individual physiological factors.
7. Influences Hepatic, Lipid, and Cardiovascular Regulation
Stanozolol is a 17-alpha-alkylated anabolic steroid associated with clinically important hepatic risks.
It can also adversely affect lipid metabolism, including reductions in HDL cholesterol and changes associated with increased cardiovascular risk.
Potential adverse effects include liver injury, cholestasis, blood pressure changes, and cardiovascular complications.
Stanozolol carries significant health risks, including cholestatic hepatitis, peliosis hepatis, hepatic tumors, adverse cholesterol changes, cardiovascular events, endocrine suppression, infertility, and androgenic adverse effects. It may also affect mood and psychological health. Exposure during pregnancy can harm fetal development, while use in adolescents may interfere with normal growth and maturation.
The 25 mg tablet strength describes the labeled quantity of stanozolol per tablet. It does not establish an appropriate dose, administration frequency, treatment duration, or safe exposure level.
Stanozolol is an orally active synthetic anabolic-androgenic steroid whose principal mechanism involves androgen receptor activation and regulation of androgen-responsive gene transcription.
Its biological activity differs from peptide hormones, GLP-1 receptor agonists, and growth hormone secretagogues because it interacts with intracellular steroid hormone receptors.
Step 1 – Oral Administration and Gastrointestinal Absorption
In established oral pharmaceutical formulations, stanozolol is administered as a tablet and absorbed through the gastrointestinal tract.
Its 17-alpha-methyl structural modification contributes to oral activity by increasing resistance to metabolic inactivation during first-pass hepatic processing.
Step 2 – Distribution to Androgen-Responsive Tissues
Following absorption, stanozolol enters systemic circulation and reaches tissues expressing androgen receptors.
These include skeletal muscle, skin, reproductive tissues, bone, and other androgen-responsive structures.
Distribution and biological responses depend on the compound's pharmacokinetic properties and individual physiology.
Step 3 – Binding to Intracellular Androgen Receptors
Stanozolol interacts with intracellular androgen receptors, influencing receptor activation and downstream gene expression.
The resulting biological response depends on tissue characteristics, receptor availability, systemic exposure, and endocrine status.
Step 4 – Regulation of Gene Expression and Metabolic Activity
Activated androgen receptors participate in transcriptional processes associated with protein metabolism and other androgen-dependent functions.
Stanozolol does not undergo aromatization into estrogen, distinguishing its metabolic profile from testosterone and methandrostenolone.
Nevertheless, androgen receptor activation can produce both anabolic and androgenic effects.
Step 5 – Hepatic Metabolism and Elimination
Stanozolol undergoes extensive metabolic processing involving the liver.
Its metabolites have been studied extensively in pharmacology and anti-doping analysis.
An oral elimination half-life of approximately nine hours is frequently reported, although estimates vary and modern pharmacokinetic evidence is limited.
Detection of metabolites after exposure does not establish the duration of pharmacological activity or verify the characteristics of a particular Biochem-labeled preparation.
Stanozolol has historically been manufactured in oral tablet and injectable suspension formulations. These pharmaceutical forms are not interchangeable and have different formulation requirements.
The Biochem Winstrol 25 mg oral tablet presentation is described by the following characteristics:
- Stanozolol as the labeled active ingredient.
- A labeled strength of 25 mg per tablet.
- A package quantity of 100 tablets.
- A total labeled active ingredient content of 2,500 mg.
- Synthetic dihydrotestosterone-derived steroid structure.
- A distinctive fused pyrazole ring.
- A 17-alpha-methyl structural modification.
- Androgen receptor agonist activity.
- Anabolic and androgenic biological effects.
- Absence of aromatization into estrogen.
- Oral solid-dose pharmaceutical presentation.
- Hepatic metabolism and potential liver toxicity.
- Possible endocrine suppression.
- Potential adverse changes in blood lipid profiles.
- Cardiovascular and reproductive safety concerns.
- Excipients selected for tablet manufacturing and stability.
- Formulation-dependent dissolution and absorption.
- Packaging intended to protect tablets from environmental exposure.
- Product identity, purity, and content uniformity requiring analytical verification.
The precise formulation, excipient composition, tablet appearance, and manufacturing specifications of Biochem Winstrol 25 mg have not been confirmed.
The presence of 100 tablets does not establish an appropriate treatment duration or individual prescription. The Biochem product should not be represented as authentic branded Winstrol or as an approved interchangeable generic without independent verification.
United States
Biochem Winstrol 25mg, Biochem Stanozolol 25mg, Winstrol 100 tablets, Stanozolol 100 tablets, Winstrol United States, Stanozolol oral tablets, Stanozolol anabolic androgenic steroid, Winstrol pharmacology, Stanozolol mechanism of action, Winstrol androgen receptor, Stanozolol protein metabolism, Winstrol molecular formula, Stanozolol chemical structure, Winstrol oral formulation, Stanozolol liver effects, Winstrol historical medical uses, Stanozolol safety information, Winstrol tablet specifications.
Canada
English: Biochem Winstrol 25mg Canada, Stanozolol 25mg Canada, Winstrol 100 tablets Canada, Stanozolol oral tablets, Winstrol anabolic steroid, Stanozolol properties, Winstrol pharmacology, Stanozolol androgen receptor, Winstrol protein metabolism, Stanozolol molecular structure, Winstrol mechanism of action, Stanozolol liver effects, Winstrol safety information.
French: Biochem Winstrol 25 mg Canada, stanozolol 25 mg, Winstrol 100 comprimés, stéroïde anabolisant androgène, propriétés du stanozolol, pharmacologie du Winstrol, récepteur des androgènes, métabolisme des protéines, structure moléculaire du stanozolol, effets hépatiques, mécanisme d'action du Winstrol, composition des comprimés, informations de sécurité.
United Kingdom
Biochem Winstrol 25mg UK, Stanozolol 25mg UK, Winstrol 100 tablets, Stanozolol oral anabolic steroid, Winstrol properties, Stanozolol pharmacology, Winstrol androgen receptor, Stanozolol protein metabolism, Winstrol molecular composition, Stanozolol mechanism of action, Winstrol liver effects, Stanozolol historical clinical information, Winstrol tablet formulation.
Germany
Biochem Winstrol 25 mg Deutschland, Stanozolol 25 mg, Winstrol 100 Tabletten, orales anaboles Steroid, Stanozolol Eigenschaften, Winstrol Wirkungsmechanismus, Stanozolol Zusammensetzung, Androgenrezeptor, Proteinstoffwechsel, anabole Wirkung, androgene Wirkung, Stanozolol Molekülstruktur, Leberstoffwechsel, Winstrol Sicherheitsinformationen, historische medizinische Anwendung.
France
Biochem Winstrol 25 mg France, stanozolol 25 mg, Winstrol 100 comprimés, stéroïde anabolisant oral, propriétés du stanozolol, mécanisme d'action du Winstrol, composition du stanozolol, récepteur des androgènes, métabolisme des protéines, activité anabolique, activité androgénique, structure moléculaire, métabolisme hépatique, effets hépatiques, informations de sécurité.
Spain
Biochem Winstrol 25 mg España, estanozolol 25 mg, Winstrol 100 tabletas, esteroide anabólico oral, propiedades del estanozolol, cómo funciona el Winstrol, composición del estanozolol, receptor de andrógenos, metabolismo de proteínas, actividad anabólica, actividad androgénica, estructura molecular, metabolismo hepático, efectos sobre el hígado, mecanismo de acción del Winstrol, información de seguridad.
Italy
Biochem Winstrol 25 mg Italia, stanozololo 25 mg, Winstrol 100 compresse, steroide anabolizzante orale, proprietà dello stanozololo, meccanismo d'azione del Winstrol, composizione dello stanozololo, recettore degli androgeni, metabolismo proteico, attività anabolica, attività androgenica, struttura molecolare, metabolismo epatico, effetti sul fegato, informazioni di sicurezza.
Portugal
Biochem Winstrol 25 mg Portugal, estanozolol 25 mg, Winstrol 100 comprimidos, esteroide anabolizante oral, propriedades do estanozolol, mecanismo de ação do Winstrol, composição do estanozolol, recetor de androgénios, metabolismo das proteínas, atividade anabólica, atividade androgénica, estrutura molecular, metabolismo hepático, efeitos hepáticos, informações de segurança.
Netherlands
Biochem Winstrol 25 mg Nederland, stanozolol 25 mg, Winstrol 100 tabletten, oraal anabool steroïde, eigenschappen van stanozolol, werkingsmechanisme Winstrol, samenstelling van stanozolol, androgeenreceptor, eiwitmetabolisme, anabole activiteit, androgene activiteit, moleculaire structuur, levermetabolisme, effecten op de lever, veiligheidsinformatie.
Belgium
Biochem Winstrol 25 mg Belgium, Winstrol 25 mg België, stanozolol 25 mg, Winstrol 100 tabletten, Winstrol 100 comprimés, anabole steroïde, stéroïde anabolisant, eigenschappen van stanozolol, propriétés du stanozolol, androgeenreceptor, récepteur des androgènes, eiwitmetabolisme, métabolisme des protéines, levermetabolisme, métabolisme hépatique, veiligheidsinformatie.
Switzerland
Biochem Winstrol 25 mg Switzerland, Winstrol 25 mg Schweiz, Winstrol 25 mg Suisse, Stanozolol 25 mg, Winstrol 100 Tabletten, Winstrol 100 comprimés, anaboles Steroid, stéroïde anabolisant, Stanozolol Eigenschaften, propriétés du stanozolol, Androgenrezeptor, récepteur des androgènes, Proteinstoffwechsel, métabolisme des protéines, Leberstoffwechsel, métabolisme hépatique.
Austria
Biochem Winstrol 25 mg Österreich, Stanozolol 25 mg, Winstrol 100 Tabletten, orales anaboles Steroid, Stanozolol Eigenschaften, Winstrol Wirkungsmechanismus, Androgenrezeptor, Proteinstoffwechsel, anabole Wirkung, androgene Wirkung, Molekülstruktur, Leberstoffwechsel, Winstrol Zusammensetzung, Sicherheitsinformationen.
Sweden
Biochem Winstrol 25 mg Sverige, stanozolol 25 mg, Winstrol 100 tabletter, oralt anabolt steroid, stanozolol egenskaper, Winstrol verkningsmekanism, androgenreceptor, proteinmetabolism, anabol aktivitet, androgen aktivitet, molekylstruktur, levermetabolism, Winstrol farmakologi, säkerhetsinformation.
Norway
Biochem Winstrol 25 mg Norge, stanozolol 25 mg, Winstrol 100 tabletter, oralt anabolt steroid, stanozolol egenskaper, Winstrol virkningsmekanisme, androgenreseptor, proteinmetabolisme, anabol aktivitet, androgen aktivitet, molekylstruktur, levermetabolisme, Winstrol farmakologi, sikkerhetsinformasjon.
Denmark
Biochem Winstrol 25 mg Danmark, stanozolol 25 mg, Winstrol 100 tabletter, oralt anabolsk steroid, stanozolol egenskaber, Winstrol virkningsmekanisme, androgenreceptor, proteinmetabolisme, anabol aktivitet, androgen aktivitet, molekylstruktur, levermetabolisme, Winstrol farmakologi, sikkerhedsinformation.
Finland
Biochem Winstrol 25 mg Suomi, stanotsololi 25 mg, Winstrol 100 tablettia, suun kautta otettava anabolinen steroidi, stanotsololin ominaisuudet, Winstrol vaikutusmekanismi, androgeenireseptori, proteiiniaineenvaihdunta, anabolinen aktiivisuus, androgeeninen aktiivisuus, molekyylirakenne, maksametabolia, Winstrol farmakologia, turvallisuustiedot.
Poland
Biochem Winstrol 25 mg Polska, stanozolol 25 mg, Winstrol 100 tabletek, doustny steryd anaboliczny, właściwości stanozololu, mechanizm działania Winstrol, skład stanozololu, receptor androgenowy, metabolizm białek, aktywność anaboliczna, aktywność androgenna, struktura molekularna, metabolizm wątrobowy, informacje o bezpieczeństwie.
Czech Republic
Biochem Winstrol 25 mg Česko, stanozolol 25 mg, Winstrol 100 tablet, perorální anabolický steroid, vlastnosti stanozololu, mechanismus účinku Winstrol, složení stanozololu, androgenový receptor, metabolismus bílkovin, anabolická aktivita, androgenní aktivita, molekulární struktura, jaterní metabolismus, bezpečnostní informace.
Romania
Biochem Winstrol 25 mg România, stanozolol 25 mg, Winstrol 100 comprimate, steroid anabolic oral, proprietăți stanozolol, mecanism de acțiune Winstrol, compoziția stanozololului, receptor androgenic, metabolismul proteinelor, activitate anabolică, activitate androgenică, structură moleculară, metabolism hepatic, informații de siguranță.
Greece
Biochem Winstrol 25 mg Ελλάδα, στανοζολόλη 25 mg, Winstrol 100 δισκία, αναβολικό στεροειδές από του στόματος, ιδιότητες στανοζολόλης, μηχανισμός δράσης Winstrol, σύνθεση στανοζολόλης, υποδοχέας ανδρογόνων, μεταβολισμός πρωτεϊνών, αναβολική δραστηριότητα, ανδρογονική δραστηριότητα, μοριακή δομή, ηπατικός μεταβολισμός, πληροφορίες ασφάλειας.
Ireland
Biochem Winstrol 25mg Ireland, Stanozolol 25mg Ireland, Winstrol 100 tablets, Stanozolol oral anabolic steroid, Winstrol properties, Stanozolol pharmacology, Winstrol androgen receptor, Stanozolol protein metabolism, Winstrol molecular composition, Stanozolol mechanism of action, Winstrol liver effects, Stanozolol historical clinical information, Winstrol tablet formulation.
Colombia
Biochem Winstrol 25 mg Colombia, estanozolol 25 mg Colombia, Winstrol 100 tabletas, esteroide anabólico oral, propiedades del estanozolol, cómo funciona el Winstrol, farmacología del estanozolol, composición del Winstrol, receptor de andrógenos, metabolismo de proteínas, actividad anabólica, actividad androgénica, estructura molecular, metabolismo hepático, efectos sobre el hígado, mecanismo de acción del Winstrol, información de seguridad.
Argentina
Biochem Winstrol 25 mg Argentina, estanozolol 25 mg Argentina, Winstrol 100 comprimidos, esteroide anabólico oral, propiedades del estanozolol, qué es el Winstrol, cómo actúa el estanozolol, farmacología del Winstrol, receptor de andrógenos, metabolismo de proteínas, actividad anabólica, actividad androgénica, estructura molecular, metabolismo hepático, efectos hepáticos, composición del Winstrol.
México
Biochem Winstrol 25 mg México, estanozolol 25 mg México, Winstrol 100 tabletas, esteroide anabólico oral, propiedades del estanozolol, para qué se utilizaba el Winstrol, cómo funciona el estanozolol, farmacología del Winstrol, receptor de andrógenos, metabolismo de proteínas, actividad anabólica, actividad androgénica, estructura molecular, metabolismo hepático, efectos sobre el hígado, mecanismo de acción del Winstrol.
Perú
Biochem Winstrol 25 mg Perú, estanozolol 25 mg Perú, Winstrol 100 tabletas, esteroide anabólico oral, propiedades del estanozolol, qué es el estanozolol, cómo funciona el Winstrol, farmacología del Winstrol, receptor de andrógenos, metabolismo de proteínas, actividad anabólica, actividad androgénica, estructura molecular, metabolismo hepático, efectos hepáticos, composición del Winstrol.
Venezuela
Biochem Winstrol 25 mg Venezuela, estanozolol 25 mg Venezuela, Winstrol 100 tabletas, esteroide anabólico oral, propiedades del estanozolol, qué es el Winstrol, cómo actúa el estanozolol, farmacología del Winstrol, receptor de andrógenos, metabolismo de proteínas, actividad anabólica, actividad androgénica, estructura molecular, metabolismo hepático, efectos sobre el hígado, composición del Winstrol.
Ecuador
Biochem Winstrol 25 mg Ecuador, estanozolol 25 mg Ecuador, Winstrol 100 tabletas, esteroide anabólico oral, propiedades del estanozolol, para qué se utilizaba el Winstrol, cómo funciona el estanozolol, farmacología del Winstrol, receptor de andrógenos, metabolismo de proteínas, actividad anabólica, actividad androgénica, estructura molecular, metabolismo hepático, efectos sobre el hígado, composición del Winstrol, mecanismo de acción del estanozolol, información de seguridad.
Biochem Winstrol (Stanozolol) 25mg | 100 Tablets | Oral Anabolic Steroid
Learn about Biochem Winstrol 25mg, a 100-tablet product labeled as containing stanozolol, an oral anabolic-androgenic steroid associated with androgen receptor activation, protein metabolism, and significant hepatic and cardiovascular risks.
Biochem Winstrol (Estanozolol) 25mg | 100 Tabletas | Esteroide Anabólico Oral
Conoce Biochem Winstrol 25mg, una presentación de 100 tabletas etiquetada como estanozolol, un esteroide anabólico-androgénico oral relacionado con la activación del receptor de andrógenos, el metabolismo de proteínas y riesgos hepáticos y cardiovasculares importantes.
biochem-winstrol-stanozolol-25mg-100-tablets
biochem-winstrol-estanozolol-25mg-100-tabletas
Biochem Winstrol Stanozolol 25mg package labeled as containing 100 oral tablets of stanozolol, a synthetic dihydrotestosterone-derived anabolic-androgenic steroid with androgen receptor activity.
Biochem Winstrol Estanozolol 25mg presentación etiquetada como 100 tabletas orales de estanozolol, un esteroide anabólico-androgénico sintético derivado de la dihidrotestosterona con actividad sobre el receptor de andrógenos.